Encouraging Sustainable Use of Antibiotics: A Commentary on the DRIVE-AB Recommended Innovation Incentives

Author:

Morel Chantal M.,Edwards Suzanne E.

Abstract

The ability to sustain antibiotic efficacy is directly affected by incentive models aiming to stimulate antibiotic research and development. This paper analyzes the extent to which the models proposed by the Innovative Medicine Initiative-funded research project DRIVE-AB can be expected to support sustainable use, drawing on basic economic theory and the incentives that derive from it. It then discusses the use of minimal safeguards that will be needed to support sustainable use where industry incentives have not been re-aligned with those of public health.

Publisher

Cambridge University Press (CUP)

Subject

Health Policy,General Medicine,Issues, ethics and legal aspects

Reference15 articles.

1. 3. See DRIVE-AB Final Report, supra note 2, at 15.

2. 1. DRIVE-AB, available at (last visited March 31, 2018).

3. 4. Essential Medicines and Health Products Information Portal, “Promoting Rational Use of Medicines: Core Components-WHO Policy Perspectives on Medicines,” No. 005, September 2002, available at (last visited March 31, 2018); WHO, WHO Global Strategy for Containment of Antimicrobial Resistance, 2001, available at (last visited March 31, 2018).

4. Antibiotic Pipeline Coordinators

5. 15. See DRIVE-AB Final Report, supra note 2, at 55-57.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3